Hello!
Many
of our dietary supplement clients have come to us for proactive assistance with
proper labeling and other FDA regulatory issues. Unfortunately, some
companies only found us after they had problems and were subject to enforcement
action by FDA. It is expensive and time consuming to have to respond to
FDA warning letters or have products held at the border. Further, some
violations raise the possibility of product recalls or even complete removal of
the product from the US market. My team and I do our best to alert our
clients and help them understand the FDA’s Good Manufacturing Practices (GMP)
regulations and I want to be sure you have heard about two opportunities to
learn more about them.
August
22nd from 1:00 pm to 3:00 pm Eastern Time (Webinar)
The
Natural Products Association is Sponsoring a webinar on the GMPs the effect
companies that distribute but do not manufacture their own products. FDA calls
such companies ‘Own Label Distributors’. I believe this information is crucial
for dietary supplements that want to grow and stay out of trouble with FDA.
Here is a link to registration for this webinar and a brief description
follows:
FDA
says that if your name is on the product, you are responsible for it. The agency has
issued numerous warning letters to own-label distributors for GMP
violations—Ensure your product is in compliance with GMPs by registering for
this webinar. Hear directly from FDA about their expectations are for specific
for own-label distributors, re-packagers, and re-labelers, and hear from our
industry speaker about how to achieve compliance.
September
13th and 14th In person conference in Boulder, CO
Sponsored
by The Rocky Mountain Dietary Supplement Forum: What Does FDA Really Expect
from Us?
At
this day and a half seminar you will learn directly from industry experts.
Learn how to dramatically change the outcome of your inspection with the Agency
Hear from FDA Denver District representatives on what they expect during an
inspection plus the top 483 items trended by FDA
Receive
step-by-step instructions and a template on how to respond to 483s and Warning
Letters
Interact with other industry professionals who are facing the same challenges
you are
http://www.regonline.com/builder/site/Default.aspx?EventID=1055067http://www.regonline.com/builder/site/Default.aspx?EventID=1055067
We
at FDALabels.com and Bioscience Translation & Application hope that you
find this information helpful. If however, you wish to receive
these occasional posts as newsletters, please post a reply to this entry.
Meanwhile,
we would be pleased to help you with your questions about FDA
regulations.
All
the best to you and yours!
Evelyn
No comments:
Post a Comment